Cellectis ROIC
Mi az Cellectis ROIC?
A ROIC az Cellectis - -32.59%
Mi a ROIC meghatározása?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC a Health Care szektor a NASDAQ-on cégekben a Cellectis -hoz képest
Mit csinál Cellectis?
cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited t-cells (ucart). by capitalizing on its 18 years of expertise in gene editing – built on its flagship talen® technology and pioneering electroporation system pulseagile – cellectis uses the power of the immune system to target and eradicate cancer cells. using its life-science-focused, pioneering genome engineering technologies, cellectis’ goal is to create innovative products in multiple fields and with various target markets. cellectis is listed on the nasdaq market (ticker: clls) and on the nyse alternext market (ticker: alcls). to find out more about us, visit our website: www.cellectis.com talking about gene editing? we do it. talen® is a registered trademark owned by the cellectis group.
roic -hoz hasonló cégek Cellectis
- Avesoro Resources nak ROIC -32.77% van
- Pharmadrug nak ROIC -32.75% van
- Five Prime Therapeutics Inc nak ROIC -32.73% van
- Electreon Wireless Ltd nak ROIC -32.68% van
- Xenetic Biosciences Inc nak ROIC -32.65% van
- Miniluxe Corp nak ROIC -32.64% van
- Cellectis nak ROIC -32.59% van
- Sonoma Pharmaceuticals nak ROIC -32.49% van
- Contact Gold nak ROIC -32.49% van
- Apache nak ROIC -32.48% van
- CHAR Technologies nak ROIC -32.46% van
- Fangdd Network Ltd nak ROIC -32.43% van
- Golden Independence Mining nak ROIC -32.42% van